Randomized Controlled Trial
Copyright ©The Author(s) 2016.
World J Gastrointest Endosc. Nov 16, 2016; 8(19): 716-722
Published online Nov 16, 2016. doi: 10.4253/wjge.v8.i19.716
Figure 2
Figure 2 From the day of endoscopic submucosal dissection, intravenous infusion of proton pump inhibitor (lansoprazole 30 mg) was administered to all patients for 2 d. Then, oral intake was initiated and patients in the vonoprazan group were administered vonoprazan (20 mg daily) and patients in the lansoprazole group were administered lansoprazole (30 mg daily) until 28 d after ESD. Patients underwent follow-up EGD on day 8 and day 28. ESD: Endoscopic submucosal dissection; PPI: Proton pump inhibitor; iv: Intravenous injection.